Search Results for "scfas and metabolites"

Experiment #00000075

Polystyrene nanoplastics (PS-NPs) may act as a scaffold for the recruitment and accumulation of WDR44 at the lysosomal membrane, thereby accelerating the de novo aggregation of alpha-synuclein in the early stages of PD.

Nanoplastic exposure _gates_from_nanoplastic_exposure Lysosomal Storage Diseases _gates_to_lysosomal_storage_diseases _gates_from_lysosomal_storage_diseases alpha-Synuclein _gates_to_alpha_synuclein WDR44 _gates_from_wdr44 Protein Aggregates

View Results

Experiment #00000073

Can botulinum toxin A (BTX-A) be repurposed from cosmetic/spasticity applications in order to treat oculomotor palsy and have utilization with endoscopic endonasal approaches to skull base tumors to protect cranial nerves?

Botulinum Toxins, Type A _gates_from_botulinum_toxins__type_a Muscle Relaxation _gates_to_muscle_relaxation _gates_from_muscle_relaxation Neuroprotection _gates_to_neuroprotection Oculomotor Nerve Diseases _gates_from_oculomotor_nerve_diseases BTX-A

View Results

Experiment #00000066

Are there any wellness alternatives for Von Willebrand Disease?

von Willebrand Diseases _gates_from_von_willebrand_diseases Multidisciplinary Care _gates_to_multidisciplinary_care _gates_from_multidisciplinary_care Transcutaneous Electric Nerve Stimulation _gates_to_transcutaneous_electric_nerve_stimulation Electric Stimulation Therapy _gates_to_electric_stimulation_therapy _gates_from_electric_stimulation_therapy

View Results

Experiment #00000065

Does pathologically seeded TDP-43 exit the retina via anterograde axonal transport along the optic tract to midbrain hubs, enter the systemic circulation inside extracellular vesicles, and subsequently traffic into pancreatic beta-cells to accelerate type 2 diabetes phenotypes?

TAR DNA-Binding Protein 43 _gates_from_tar_dna_binding_protein_43 Extracellular Vesicles _gates_to_extracellular_vesicles Systemic circulating EVs _gates_from_systemic_circulating_evs Insulin-Secreting Cells _gates_to_insulin_secreting_cells Axonal Transport _gates_to_axonal_transport

View Results

Experiment #00000063

What specific structural modifications to the pyrrolidinone scaffold led to improved potency against SARM1 compared to earlier inhibitor classes?

Pyrrolidinones _gates_from_pyrrolidinones SARM1 _gates_to_sarm1 Sterile Alpha and TIR Motif Containing 1 _gates_from_sterile_alpha_and_tir_motif_containing_1 Axonal Degeneration _gates_to_axonal_degeneration Molecular Structure _gates_from_molecular_structure

View Results

Experiment #00000062

NESCO-induced pyroptosis in the peritoneal microenvironment might be attenuated by the upregulation of 11-oxygenated androgens in the systemic circulation.

Endometriosis _gates_from_endometriosis Tumor Microenvironment _gates_to_tumor_microenvironment Androgens _gates_from_androgens _gates_to_endometriosis Disease Models, Animal _gates_from_disease_models__animal NESCO and Androgens

View Results

Experiment #00000056

Sarcopenia and Amyotrophic Lateral Sclerosis: Biological Pathways and Analysis

Motor Neuron Disease _gates_from_motor_neuron_disease Neuromuscular Junction Diseases _gates_to_neuromuscular_junction_diseases _gates_from_neuromuscular_junction_diseases Muscle Weakness _gates_to_muscle_weakness NMJ instability _gates_from_nmj_instability Sarcopenia

View Results

Experiment #00000054

What dietary habits are beneficial towards reducing excess/harmful tyramine in order to improve liver and gut health?

Dietary Proteins _gates_from_dietary_proteins Aromatic-L-Amino-Acid Decarboxylases _gates_to_aromatic_l_amino_acid_decarboxylases _gates_from_aromatic_l_amino_acid_decarboxylases Tyramine _gates_to_tyramine _gates_from_tyramine Gastrointestinal Diseases _gates_to_gastrointestinal_diseases

View Results

Experiment #00000053

How do specific microbial-derived metabolites, beyond short-chain fatty acids and bile acids, function as 'molecular switches' to program hepatic lipid metabolism during the earliest stages of steatotic liver disease?

Microbial composition _gates_from_microbial_composition Metabolomics _gates_to_metabolomics _gates_from_metabolomics Signal Transduction _gates_to_signal_transduction Host signaling _gates_from_host_signaling Lipid Metabolism

View Results

Experiment #00000050

What are the symptoms of toxoplasmosis and how is it transmitted?

Host _gates_from_host Infection _gates_to_infection _gates_from_infection Clinical Symptoms _gates_to_clinical_symptoms Animals, Domestic _gates_from_animals__domestic Environment

View Results

Experiment #00000049

Explain the risks of veridical AI and human job displacement.

Artificial Intelligence _gates_from_artificial_intelligence Efficiency, Organizational _gates_to_efficiency__organizational _gates_from_efficiency__organizational Employment _gates_to_employment _gates_from_employment Patient-Centered Care _gates_to_patient_centered_care

View Results

Experiment #00000048

The ALS-T2D comorbidity is driven by a bidirectional, exosome-mediated proteostatic collapse. Peripheral tissues (muscle, pancreas) dictate CNS TDP-43 stability via exosomal miRNAs (miR-126a-5p) and glucose-dependent modifications (O-GlcNAcylation). Conversely, pharmacological activation of ubiquitin-peptidases (e.g., Acarbose targeting USP46) or restitution of glycolytic cofactors (F2,6BP) represent novel, cross-disciplinary therapeutic targets capable of halting systemic proteinopathy.

Diabetes Mellitus, Type 2 _gates_from_diabetes_mellitus__type_2 Extracellular Vesicles _gates_to_extracellular_vesicles _gates_from_extracellular_vesicles DNA-Binding Proteins _gates_to_dna_binding_proteins _gates_from_dna_binding_proteins Amyotrophic Lateral Sclerosis _gates_to_amyotrophic_lateral_sclerosis

View Results

Experiment #00000047

Does blast-induced mild traumatic brain injury (mTBI) drive progressive tau/TDP-43 seeding by disrupting astrocytic AQP4 glymphatic clearance and activating microglial cGAS-STING neuroinflammation? #mTBI #Glymphatic #cGASSTING

Blast Injuries _gates_from_blast_injuries Aquaporin 4 _gates_to_aquaporin_4 _gates_from_aquaporin_4 Glymphatic System _gates_to_glymphatic_system _gates_from_glymphatic_system Protein Aggregates _gates_to_protein_aggregates

View Results

Experiment #00000045

Sporadic ALS and C9orf72 affected ALS are two different pathologies and the mixing of test groups and datasets has produced confounding results.

Molecular Heterogeneity _gates_from_molecular_heterogeneity Diagnostic Errors _gates_to_diagnostic_errors Biomarkers _gates_to_biomarkers Genetic Heterogeneity _gates_from_genetic_heterogeneity Molecular Typing _gates_to_molecular_typing

View Results

Experiment #00000043

Subject-specific prognostic models can now predict articulatory precision and ALSFRS-R speech subscores 30–90 days in advance.

Speech-Language Pathology _gates_from_speech_language_pathology Algorithms _gates_to_algorithms _gates_from_algorithms Amyotrophic Lateral Sclerosis _gates_to_amyotrophic_lateral_sclerosis Speech _gates_from_speech Bulbar Palsy

View Results

Experiment #00000039

What is the current evidence for RGNEF (ARHGEF28) functioning as a primary upstream regulator of axonal transport and TDP-43 homeostasis in ALS, and how does the failure of this 'terminal tether' initiate the pathological continuum compared to downstream protein aggregation?

Metabolic Stress _gates_from_metabolic_stress Protein Aggregation _gates_to_protein_aggregation _gates_from_protein_aggregation RNA Metabolism _gates_to_rna_metabolism _gates_from_rna_metabolism Axonal Transport _gates_to_axonal_transport

View Results

Experiment #00000038

Map the direct mechanical and axonal transport pathways connecting intranasal administration or trigeminal nerve delivery to the clearance of TDP-43 aggregates in sporadic ALS, and the delivery of CRISPR-Cas/ASO gene therapies targeting C9orf72 hexanucleotide repeat expansions in the cerebellum and brainstem.

Intranasal Route _gates_from_intranasal_route Blood-Brain Barrier _gates_to_blood_brain_barrier C9orf72 Protein _gates_to_c9orf72_protein _gates_from_c9orf72_protein Brain _gates_to_brain Intranasal Administration

View Results

Experiment #00000036

What is Karyoptosis and how does it align with past and present neurodegenerative disease research? Does Karyoptosis provide a new context in which a new class of repurposed therapeutics is formed?

Proteotoxic Stress _gates_from_proteotoxic_stress Cyclic AMP-Response Element Binding Protein _gates_to_cyclic_amp_response_element_binding_protein _gates_from_cyclic_amp_response_element_binding_protein Nuclear Envelope _gates_to_nuclear_envelope _gates_from_nuclear_envelope Apoptosis _gates_to_apoptosis

View Results

Experiment #00000033

Acinetobacter baumannii and Pseudomonas may share pathways with other pathologies and there may be therapeutic bacteriophages or other non-antibiotic solutions hidden with in PubMed literature.

Drug Resistance, Multiple, Bacterial _gates_from_drug_resistance__multiple__bacterial Anti-Bacterial Agents _gates_to_anti_bacterial_agents Multidrug resistance _gates_from_multidrug_resistance Therapeutics _gates_to_therapeutics Biofilms _gates_from_biofilms

View Results

Experiment #00000032

What is Cyclosporiasis and why do outbreaks occur? Is it preventable?

Ingestion _gates_from_ingestion Cyclosporiasis _gates_to_cyclosporiasis Food Contamination _gates_from_food_contamination _gates_to_ingestion Sanitation _gates_from_sanitation _gates_to_food_contamination

View Results

Experiment #00000031

Why are frontotemporal dementia and c9orf72 ALS considered different diseases if they are both driven by the same abnormal expansion of a GGGGCC (G₄C₂) sequence in the first intron of the C9orf72 gene? Is it logical to think that CRISPR therapeutics for FTD potentially be used for ALS as well?

C9orf72 expansion _gates_from_c9orf72_expansion Gene Expression Regulation _gates_to_gene_expression_regulation _gates_from_gene_expression_regulation Protein Aggregation, Pathological _gates_to_protein_aggregation__pathological _gates_from_protein_aggregation__pathological CRISPR-Cas Systems _gates_to_crispr_cas_systems

View Results

Experiment #00000030

Can AI and single-cell RNA sequencing help map cryptic TDP-43 splicing errors in sporadic ALS to design BBB-penetrant CRISPR gene therapies before neurotoxicity begins?

Single-Cell Analysis _gates_from_single_cell_analysis RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Blood-Brain Barrier _gates_to_blood_brain_barrier _gates_from_blood_brain_barrier Neurotoxicity Syndromes _gates_to_neurotoxicity_syndromes

View Results

Experiment #00000029

Why do people get tinnitus and are there any wellness alternatives to help reduce the impact it has on lifestyle and comfort?

Cochlear Diseases _gates_from_cochlear_diseases Neuronal Plasticity _gates_to_neuronal_plasticity _gates_from_neuronal_plasticity Tinnitus _gates_to_tinnitus _gates_from_tinnitus Health Promotion _gates_to_health_promotion

View Results

Experiment #00000027

How does eating legumes and vegetables help restore gut-brain axis homeostasis?

Vegetables _gates_from_vegetables Gastrointestinal Microbiome _gates_to_gastrointestinal_microbiome _gates_from_gastrointestinal_microbiome Inflammation _gates_to_inflammation _gates_from_inflammation Neuroprotection _gates_to_neuroprotection

View Results

Experiment #00000024

If RGNEF fails agitate and regulate TDP-43 at the RGNEF NF242 Terminal, does this cause TDP-43 propteinopathy?

Protein Interaction Mapping _gates_from_protein_interaction_mapping RNA Stability _gates_to_rna_stability Peptide Fragments _gates_from_peptide_fragments RNA Recognition Motif _gates_to_rna_recognition_motif Metabolic stress _gates_from_metabolic_stress

View Results

Experiment #00000019

What is the role of 3-indolepropionic acid within the body, and what foods or nutrients may help replenish it if deficient?

Edible Grain _gates_from_edible_grain Clostridium sporogenes _gates_to_clostridium_sporogenes Gastrointestinal Microbiome _gates_from_gastrointestinal_microbiome 3-indolepropionic acid _gates_to_3_indolepropionic_acid _gates_from_3_indolepropionic_acid Signal Transduction

View Results

Experiment #00000016

Analyze the potential for zinc-binding competition between synaptic transporters (e.g., SLC39A8, ZnT3) and ALS-associated proteins (RGNEF, TDP-43) in the RGC-thalamic axis. Can this competition explain the coexistence of RGC excitotoxicity and STMN2 depletion in clinical samples?

TAR DNA-Binding Protein 43 _gates_from_tar_dna_binding_protein_43 Stathmin 2 _gates_to_stathmin_2 SLC39A8 protein, human _gates_from_slc39a8_protein__human Zinc _gates_to_zinc Excitotoxicity _gates_from_excitotoxicity

View Results

Experiment #00000014

Under certain conditions, can hyperexcited retinal ganglion cells misfire corollary discharge(s) unexpectedly?

Oculomotor Motor Command _gates_from_oculomotor_motor_command Corollary Discharge _gates_to_corollary_discharge _gates_from_corollary_discharge Sensory Processing, Sensory _gates_to_sensory_processing__sensory Retinal Ganglion Cells (RGCs) _gates_from_retinal_ganglion_cells__rgcs_ Visual Perception

View Results

Experiment #00000013

Can BMAA, a known glutamate mimic, cause hyperexcited retinal ganglion cells and cause them to "misfire" corollary discharge?

Amino Acids, Diamino _gates_from_amino_acids__diamino Retina _gates_to_retina _gates_from_retina Corollary Discharge _gates_to_corollary_discharge NMDA receptors _gates_to_nmda_receptors NMDA receptor activation

View Results

Experiment #00000012

If a toxin with a thermodynamic affinity for Zinc GREATER THAN that of Glutamate AND LESS THAN that of RGNEF, under certain conditions a pathway exists wherein the toxin could shuttle synaptic retinal zinc to RGNEF, thus potentially ultimately resulting in the retinal TDP-43 proteinopathy seen in the retina post mortem in Sporadic Amyotrophic Lateral Sclerosis

Synaptic Zinc _gates_from_synaptic_zinc Receptors, Glutamate _gates_to_receptors__glutamate _gates_from_receptors__glutamate Zinc Dyshomeostasis in RGCs _gates_to_zinc_dyshomeostasis_in_rgcs _gates_from_zinc_dyshomeostasis_in_rgcs TDP-43 Proteinopathy _gates_to_tdp_43_proteinopathy

View Results

Experiment #00000011

Do persistent viral reservoirs or latent viral reactivations trigger mitochondrial dysfunction and promote long-term T-cell exhaustion in patients with severe post-exertional malaise

Virus Latency _gates_from_virus_latency Antigen persistence _gates_to_antigen_persistence _gates_from_antigen_persistence Reactive Oxygen Species _gates_to_reactive_oxygen_species _gates_from_reactive_oxygen_species T-Cell Exhaustion _gates_to_t_cell_exhaustion

View Results

Experiment #00000007

Simply put, we still don’t know why neurons are dying in ALS, and why motor neurons die while other types of neurons don’t. Even for genetic forms c9orf72 familial ALS, why is it that the mutation is in every cell but the motor neurons are dying ie have increased susceptibility?

Axonal Transport _gates_from_axonal_transport Motor Neuron Disease _gates_to_motor_neuron_disease C9orf72 Repeat Expansion _gates_from_c9orf72_repeat_expansion Dipeptide Repeats _gates_to_dipeptide_repeats _gates_from_dipeptide_repeats VAPB protein, human

View Results

Experiment #00000005

What are the biomarker differences in TDP-43 proteinopathy within the cerebellum and retina when comparing Sporadic Amyotrophic Lateral Sclerosis and c9orf72 affected Familial Amyotrophic Lateral Sclerosis? Are there any mutually exclusive biomarkers that can be deduced?

C9orf72 expansion _gates_from_c9orf72_expansion Dipeptide Repeats _gates_to_dipeptide_repeats _gates_from_dipeptide_repeats Microglia _gates_to_microglia C9orf72 Protein _gates_from_c9orf72_protein Cerebellum

View Results

PathMap Literature Based Discovery Engine

Guaranteed to find unpublished literature based discoveries.

Polystyrene nanoplastics (PS-NPs) may act as a scaffold for the recruitment and accumulation of WDR44 at the lysosomal membrane, thereby accelerating the de novo aggregation of alpha-synuclein in the early stages of PD.

Can botulinum toxin A (BTX-A) be repurposed from cosmetic/spasticity applications in order to treat oculomotor palsy and have utilization with endoscopic endonasal approaches to skull base tumors to protect cranial nerves?

Are there any wellness alternatives for Von Willebrand Disease?

Does pathologically seeded TDP-43 exit the retina via anterograde axonal transport along the optic tract to midbrain hubs, enter the systemic circulation inside extracellular vesicles, and subsequently traffic into pancreatic beta-cells to accelerate type 2 diabetes phenotypes?

What specific structural modifications to the pyrrolidinone scaffold led to improved potency against SARM1 compared to earlier inhibitor classes?

NESCO-induced pyroptosis in the peritoneal microenvironment might be attenuated by the upregulation of 11-oxygenated androgens in the systemic circulation.

Sarcopenia and Amyotrophic Lateral Sclerosis: Biological Pathways and Analysis

What dietary habits are beneficial towards reducing excess/harmful tyramine in order to improve liver and gut health?

How do specific microbial-derived metabolites, beyond short-chain fatty acids and bile acids, function as 'molecular switches' to program hepatic lipid metabolism during the earliest stages of steatotic liver disease?

What are the symptoms of toxoplasmosis and how is it transmitted?

Explain the risks of veridical AI and human job displacement.

Does blast-induced mild traumatic brain injury (mTBI) drive progressive tau/TDP-43 seeding by disrupting astrocytic AQP4 glymphatic clearance and activating microglial cGAS-STING neuroinflammation? #mTBI #Glymphatic #cGASSTING

Sporadic ALS and C9orf72 affected ALS are two different pathologies and the mixing of test groups and datasets has produced confounding results.

Subject-specific prognostic models can now predict articulatory precision and ALSFRS-R speech subscores 30–90 days in advance.

What is the current evidence for RGNEF (ARHGEF28) functioning as a primary upstream regulator of axonal transport and TDP-43 homeostasis in ALS, and how does the failure of this 'terminal tether' initiate the pathological continuum compared to downstream protein aggregation?

What is Karyoptosis and how does it align with past and present neurodegenerative disease research? Does Karyoptosis provide a new context in which a new class of repurposed therapeutics is formed?

Acinetobacter baumannii and Pseudomonas may share pathways with other pathologies and there may be therapeutic bacteriophages or other non-antibiotic solutions hidden with in PubMed literature.

What is Cyclosporiasis and why do outbreaks occur? Is it preventable?

Why are frontotemporal dementia and c9orf72 ALS considered different diseases if they are both driven by the same abnormal expansion of a GGGGCC (G₄C₂) sequence in the first intron of the C9orf72 gene? Is it logical to think that CRISPR therapeutics for FTD potentially be used for ALS as well?

Can AI and single-cell RNA sequencing help map cryptic TDP-43 splicing errors in sporadic ALS to design BBB-penetrant CRISPR gene therapies before neurotoxicity begins?

Why do people get tinnitus and are there any wellness alternatives to help reduce the impact it has on lifestyle and comfort?

How does eating legumes and vegetables help restore gut-brain axis homeostasis?

If RGNEF fails agitate and regulate TDP-43 at the RGNEF NF242 Terminal, does this cause TDP-43 propteinopathy?

What is the role of 3-indolepropionic acid within the body, and what foods or nutrients may help replenish it if deficient?

Analyze the potential for zinc-binding competition between synaptic transporters (e.g., SLC39A8, ZnT3) and ALS-associated proteins (RGNEF, TDP-43) in the RGC-thalamic axis. Can this competition explain the coexistence of RGC excitotoxicity and STMN2 depletion in clinical samples?

Under certain conditions, can hyperexcited retinal ganglion cells misfire corollary discharge(s) unexpectedly?

Can BMAA, a known glutamate mimic, cause hyperexcited retinal ganglion cells and cause them to "misfire" corollary discharge?

Do persistent viral reservoirs or latent viral reactivations trigger mitochondrial dysfunction and promote long-term T-cell exhaustion in patients with severe post-exertional malaise

Simply put, we still don’t know why neurons are dying in ALS, and why motor neurons die while other types of neurons don’t. Even for genetic forms c9orf72 familial ALS, why is it that the mutation is in every cell but the motor neurons are dying ie have increased susceptibility?

What are the biomarker differences in TDP-43 proteinopathy within the cerebellum and retina when comparing Sporadic Amyotrophic Lateral Sclerosis and c9orf72 affected Familial Amyotrophic Lateral Sclerosis? Are there any mutually exclusive biomarkers that can be deduced?

See all pathway research

Need a custom Literature-Based Discovery?